Tchack J - Search Results

1

Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.

Weiss SA, Han SW, Lui K, Tchack J, Shapiro R, Berman R, Zhong J, Krogsgaard M, Osman I, Darvishian F. Weiss SA, et al. Among authors: tchack j. Hum Pathol. 2016 Nov;57:116-125. doi: 10.1016/j.humpath.2016.07.008. Epub 2016 Jul 26. Hum Pathol. 2016. PMID: 27473267 Free PMC article.

2

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.

Weiss SA, Han J, Darvishian F, Tchack J, Han SW, Malecek K, Krogsgaard M, Osman I, Zhong J. Weiss SA, et al. Among authors: tchack j. J Transl Med. 2016 Oct 19;14(1):299. doi: 10.1186/s12967-016-1026-2. J Transl Med. 2016. PMID: 27760559 Free PMC article.

3

Corrigendum to "Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma" (Hum Pathol 2016;57:116-25).

Weiss SA, Han SW, Lui K, Tchack J, Shapiro R, Berman R, Zhong J, Krogsgaard M, Osman I, Darvishian F. Weiss SA, et al. Among authors: tchack j. Hum Pathol. 2017 May;63:222. doi: 10.1016/j.humpath.2017.03.001. Epub 2017 Apr 25. Hum Pathol. 2017. PMID: 28449825 No abstract available.

4

Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care.

Goldman C, Tchack J, Robinson EM, Han SW, Moran U, Polsky D, Berman RS, Shapiro RL, Ott PA, Osman I, Zhong H, Pavlick AC, Wilson MA. Goldman C, et al. Among authors: tchack j. Oncology. 2017;93(3):164-176. doi: 10.1159/000475715. Epub 2017 Jun 10. Oncology. 2017. PMID: 28601879

5

Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.

Robinson EM, Rosenbaum BE, Zhang Y, Rogers R, Tchack J, Berman RS, Darvishian F, Osman I, Shapiro RL, Shao Y, Polsky D. Robinson EM, et al. Among authors: tchack j. J Surg Oncol. 2018 Jul;118(1):150-156. doi: 10.1002/jso.25111. Epub 2018 Jun 7. J Surg Oncol. 2018. PMID: 29878361

6

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.

Gowen MF, Giles KM, Simpson D, Tchack J, Zhou H, Moran U, Dawood Z, Pavlick AC, Hu S, Wilson MA, Zhong H, Krogsgaard M, Kirchhoff T, Osman I. Gowen MF, et al. Among authors: tchack j. J Transl Med. 2018 Apr 2;16(1):82. doi: 10.1186/s12967-018-1452-4. J Transl Med. 2018. PMID: 29606147 Free PMC article.

7

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.

Lattanzi M, Han J, Moran U, Utter K, Tchack J, Sabado RL, Berman R, Shapiro R, Huang HH, Osman I, Bhardwaj N, Pavlick AC. Lattanzi M, et al. Among authors: tchack j. J Immunother Cancer. 2018 May 18;6(1):38. doi: 10.1186/s40425-018-0345-7. J Immunother Cancer. 2018. PMID: 29773080 Free PMC article.

8

A 46-Year-Old Woman With Chronic Dyspnea and Diarrhea.

Kshattry S, White M, Tchack J, Laskin W, Kunz PL. Kshattry S, et al. Among authors: tchack j. Chest. 2023 Jan;163(1):e23-e29. doi: 10.1016/j.chest.2022.08.2214. Chest. 2023. PMID: 36628681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters